Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New patent issues covering Cytoclonal's novel methods of producing paclitaxel

March 15, 1999

New DAG analogues acting as PKC agonists or antagonists

March 15, 1999

Warner-Lambert prepares irreversible tyrosine kinase inhibitors

March 12, 1999

U.K. is country of first launch for Schering-Plough's oral alkylating agent

March 12, 1999

ImClone receives milestone payment for C225 clinical advance

March 12, 1999

Amgen and Praecis to develop and commercialize abarelix

March 12, 1999

New U.S. patent broadens the base of ImmunoGen's TAP technology

March 12, 1999

Techniclone enters licensing agreement for Oncolym with Schering AG

March 12, 1999

NCI to conduct further testing of Lorus anticancer compounds

March 12, 1999

Protein prenylation inhibitors under study at Pierre Fabre for use in cancer, etc.

March 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...